Advertisement
Review| Volume 41, ISSUE 2, P317-328, August 2020

Download started.

Ok

The effects of nutrients on symptoms in women with endometriosis: a systematic review

      Highlights

      • Diet interventions may be effective as self-management strategy in women with endometriosis
      • Nutrients with anti-inflammatory properties may suppress endometriosis symptoms

      Abstract

      The success rate of medical and surgical treatment for endometriosis is limited. Empowering patients suffering from endometriosis by giving them opportunities to positively influence their symptoms could result in increased quality of life. Changing diet is one of these self-management activities, but current endometriosis diets are mostly based on limited evidence. In order to gain more insight into the role of nutrients on symptoms in women with endometriosis a systematic review was carried out in which the effect of a nutrient or diet on endometriosis-related symptoms was investigated. PubMed and the Cochrane Database of Systematic Reviews were searched for relevant articles up to 1 March 2019. Search terms included endometriosis, diet, and 26 possible nutrients were identified after assessing available endometriosis diets in the literature and on the internet. Twelve studies were included. Study quality, including risk of bias, was assessed using GRADE criteria and all were of low to very low quality. Intake of additional fatty acids, antioxidants and a combination of vitamins and minerals may have a positive effect on endometriosis-associated symptoms. Future studies are necessary to gain evidence about which food products are effective and in which amounts.

      Keywords

      Introduction

      Endometriosis is one of the most prevalent benign gynaecological diseases, affecting 6–10% of women of reproductive age (
      • Giudice L.C.
      Clinical practice. Endometriosis.
      ). Endometriosis is defined as the presence of functioning endometrium-like tissue outside the uterine cavity (
      • Giudice L.C.
      Clinical practice. Endometriosis.
      ). It is a debilitating disease characterized by dysmenorrhoea, dyspareunia, dyschezia, dysuria and infertility, but there may also be many unspecific complaints like pelvic pain, fatigue, bloating and back pain (
      • Dunselman G.A.
      • Vermeulen N.
      • Becker C.
      • Calhaz-Jorge C.
      • D'Hooghe T.
      • De Bie B.
      • Heikinheimo O.
      • Horne A.W.
      • Kiesel L.
      • Nap A.
      • Prentice A.
      • Saridogan E.
      • Soriano D.
      • Nelen W.
      ESHRE guideline: management of women with endometriosis.
      ). Symptoms often force women to refrain from professional and social activities (
      • De Graaff A.A.
      • D'Hooghe T.M.
      • Dunselman G.A.J.
      • Dirksen C.D.
      • Hummelshoj L.
      • Simoens S.
      WERF EndoCost Consortium
      The significant effect of endometriosis on physical, mental and social wellbeing: results from an international cross–sectional survey.
      ). Diagnostic delay is considerable due to a lack of non-invasive reliable diagnostic testing, and to the lack of awareness in medical professionals because of the often non-specific symptoms with which women are presenting to their doctors (
      • Van der Zanden M.
      • Arens M.W.J.
      • Braat D.D.M.
      • Nelen W.L.M.
      • Nap A.W.
      Gynaecologists’ view on diagnostic delay and care performance in endometriosis in the Netherlands.
      ). The delay in diagnosis varies in different reports in the literature and can be 7–10 years from onset of symptoms (
      • Arruda M.S.
      • Petta C.A.
      • Abrão M.S.
      • Benetti-Pinto C.L.
      Time elapsed from onset of symptoms to diagnosis of endometriosis in a cohort study of Brazilian women.
      ;
      • Ballard K.
      • Lowton K.
      • Wright J.
      What's the delay? A qualitative study of women's experiences of reaching a diagnosis of endometriosis.
      ;
      • Hadfield R.
      • Mardon H.
      • Barlow D.
      • Kennedy S.
      Delay in the diagnosis of endometriosis: a survey of women from the USA and the UK.
      ;
      • Hudelist G.
      • Fritzer N.
      • Thomas A.
      • Niehues C.
      • Oppelt P.
      • Haas D.
      • Tammaa A.
      • Salzer H.
      Diagnostic delay for endometriosis in Austria and Germany: causes and possible consequences.
      ). Because of the delay and the severity of symptoms, costs to society are high due to the (partial) inability to work and to the necessity for psychological support because of pain and infertility (
      • Simoens S.
      • Dunselman G.
      • Dirksen C.
      • Hummelshoj L.
      • Bokor A.
      • Brandes I.
      • Brodszky V.
      • Canis M.
      • Colombo G.L.
      • DeLeire T.
      • Falcone T.
      • Graham B.
      • Halis G.
      • Horne A.
      • Kanj O.
      • Kjer J.J.
      • Kristensen J.
      • Lebovic D.
      • Mueller M.
      • Vigano P.
      • Wullschleger M.
      • D'Hooghe T.
      The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres.
      ).
      The pathogenesis of endometriosis has not been fully elucidated. The most widely accepted theory is that of retrograde menstruation. Endometriosis may occur when menstrual debris is transported through the tubes and enters the abdominal cavity, where it can attach and adhere to the peritoneal lining (
      • Sampson J.A.
      Peritoneal endometriosis due to menstrual dissemination of endometrial tissue into the peritoneal cavity.
      ). However, retrograde menstruation is seen in 90% of women with patent tubes, whereas symptomatic endometriosis is present in only approximately 10% of women (
      • Halme J.
      • Becker S.
      • Hammond M.G.
      • Raj S.G.
      • Talbert L.M.
      Retrograde menstruation in healthy women and in patients with endometriosis.
      ). Different genetic, immunological, environmental and hormonal factors may be involved in the development of endometriosis and may explain the difference between the occurrence of retrograde menstruation and the presence of endometriosis (
      • Giudice L.C.
      Clinical practice. Endometriosis.
      ). However, the exact contribution of these factors is still unknown.
      Endometriosis can currently be treated pharmacologically and/or surgically. Treatment is individualized and depends on severity, character and location of symptoms, and on the presence or absence of the wish to conceive. Analgesics may be used to suppress pain symptoms when there is a desire to achieve pregnancy. Anti-inflammatory agents can be prescribed in order to suppress prostaglandin activity. Prostaglandin activity plays a role in the inflammatory reaction, which in turn causes pain in active endometriosis (
      • Wu M.H.
      • Shoji Y.
      • Chuang P.C.
      • Tsai S.J.
      Endometriosis: disease pathophysiology and the role of prostaglandins.
      ). When there is no wish to conceive, suppression of endometriosis may be aimed at by suppressing oestrogen activity (
      • Dunselman G.A.
      • Vermeulen N.
      • Becker C.
      • Calhaz-Jorge C.
      • D'Hooghe T.
      • De Bie B.
      • Heikinheimo O.
      • Horne A.W.
      • Kiesel L.
      • Nap A.
      • Prentice A.
      • Saridogan E.
      • Soriano D.
      • Nelen W.
      ESHRE guideline: management of women with endometriosis.
      ). This can be achieved by using oral contraceptives, progestogens or gonadotrophin-releasing hormone (GnRH) analogues. Dysmenorrhoea may be effectively decreased by suppressing the menstrual cycle (
      • Dunselman G.A.
      • Vermeulen N.
      • Becker C.
      • Calhaz-Jorge C.
      • D'Hooghe T.
      • De Bie B.
      • Heikinheimo O.
      • Horne A.W.
      • Kiesel L.
      • Nap A.
      • Prentice A.
      • Saridogan E.
      • Soriano D.
      • Nelen W.
      ESHRE guideline: management of women with endometriosis.
      ). Moreover, by suppressing oestrogen activity the progress of disease may be prevented, thereby protecting women against future damage caused by endometriosis, including adhesions and infertility (
      • Koga K.
      • Takamura M.
      • Fujii T.
      • Osuga Y.
      Prevention of the recurrence of symptom and lesions after conservative surgery for endometriosis.
      ). Surgical excision of endometriosis lesions may also be effective to treat pain symptoms. However, surgical procedures are often complex and surgical treatment has a risk of complications. Risk of recurrence of symptoms is 40–50% after 5 years (
      • Vercellini P.
      • Crosignani P.G.
      • Abbiati A.
      • Somigliana E.
      • Viganò P.
      • Fedele L.
      The effect of surgery for symptomatic endometriosis: the other side of the story.
      ). To date, there is no definitive cure for endometriosis.
      Because of the limited amount of success of treatment and because of the chronic character of endometriosis, many women feel the need to be in control of this disease themselves and they are looking for tools to do so. Empowering patients suffering from chronic diseases, including endometriosis, by giving them opportunities to positively influence their pain could result in decreased feelings of helplessness and increased quality of life (
      • O'Hara R.
      • Rowe H.
      • Fisher J.
      Self-management in condition-specific health: a systematic review of the evidence among women diagnosed with endometriosis.
      ). Self-management activities may be important empowering tools. According to an Australian national online survey, up to 76% of women with endometriosis use self-management strategies, consisting of diverse self-care and lifestyle choices, such as meditation, exercise and nutrition. Almost half (44%) of the women tried to manage their endometriosis themselves with adaptation of dietary choices, such as a gluten-free or vegan diet. The effectiveness of the dietary choices was rated with a score of 6.4 out of 10 in this online national survey (
      • Armour M.
      • Sinclair J.
      • Chalmers J.K.
      • Smith C.A.
      Self-management strategies amongst Australian women with endometriosis: a national online survey.
      ).
      Numerous sources can be found on the internet promoting dietary restrictions or full diets for the treatment of endometriosis. These diets are often created by patients themselves and are based on their own experience instead of scientific evidence. Implementing the dietary changes from these diets could result in nutritional deficiencies, as many food products are excluded from the diet and not adequately replaced. Furthermore, adherence to the diet may be costly in both money and time. Finally, women often report feelings of guilt and stress when they do not manage to adhere to the diet. There is little scientific evidence for the effects of nutrition on endometriosis. Most studies about the association between nutrition and endometriosis are case–control studies investigating dietary intake and endometriosis risk instead of the role in treatment. The aim of this review is to provide evidence for the effects of nutrition on symptoms in women with endometriosis. A scientific basis for the benefit of dietary interventions is necessary in order to be able to advise women about the effects of nutrients on the symptoms of endometriosis.

      Materials and methods

      Eligibility criteria

      Inclusion criteria were: study populations investigating women with surgically or magnetic resonance imaging/ultrasound-confirmed endometriosis; studies concerning the effect of a nutrient or diet on endometriosis-related symptoms; studies written in English in a peer-reviewed journal. All study designs using quantitative or qualitative methods were included. Exclusion criteria were: study populations investigating women with unconfirmed endometriosis, animal studies, laboratory studies, narrative review articles and organizational guidelines, in an attempt to focus the review on primary literature. Conference abstracts were also excluded.

      Information sources

      This systematic review was designed to meet the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. A systematic research was conducted to search for relevant articles in which an effect of a nutrient was described on pain, fertility or quality of life associated with endometriosis. PubMed and the Cochrane Database of Systematic Reviews (Cochrane Library) were searched from database inception until 1 March 2019.

      Search strategy

      First a general search (Search 1) was carried out: ‘endometriosis and diet’. After that a more specific search (Search 2) was done, in which all search terms were converted into ‘MeSH terms’ and corresponding ‘entry terms’. A combination of relevant vocabulary terms together with free-text terms searched in the title or abstract was used. The following 26 search terms were input into PubMed: antioxidants, ascorbic acid, beta carotene, caffeine, carbohydrates, coffee, copper, dietary fibre, dietary product, ethanol, fruit, gluten, Lepidium, lipids, locust bean gum, organic food, soy, sweetening agents, toxin, Triticum, vegetables, vegetarian diet, vitamin A, vitamin D, vitamin E and zinc.
      Different combinations with endometriosis were formed by using Boolean operators (AND, OR and NOT) to connect various pieces of information.
      From MeSH terms and corresponding entry terms, components were made of an entire search string. Two search strings were used, and for every dietary component a search string was made consisting of three parts (1 = related to endometriosis, 2 = related to dietary component, 3 = related to diet) (see Supplementary data).

      Study selection

      A two-stage process was used to assess eligibility for inclusion. First, an initial search of the literature was undertaken in which both reviewers (A.N., E.H.) separately assessed all articles on title and abstract in order to select relevant articles potentially meeting the inclusion criteria. Then, reviewers shared their list of studies that needed to be read in full text. The full text of potentially relevant articles was retrieved to assess whether the paper should be included. Full-text articles were reviewed and uncertainties were discussed until consensus was reached among the authors.

      Data extraction

      Data were extracted into an evidence table in which the following items were described: author and publication date, number of participants, study design, age of participants, type of endometriosis, dietary component, dosage/intervention/duration, end-point of study, result, P-value and quality of evidence (Table 1).
      Table 1Summary of data extracted from the included articles
      Author/date, number of patientsStudy design / type of studyAge (years)Type of endometriosisDietary componentDosage / intervention / durationEnd-point of studyResultP-valueQuality of evidence (GRADE)
      Vitamin D
      • Ailawadi R.K.
      • Jobanputra S.
      • Kataria M.
      • Gurates B.
      • Bulun S.E.
      Treatment of endometriosis and chronic pelvic pain with letrozole and norethindrone acetate: a pilot study.


      n = 10
      Phase 2 open-label non-randomized proof of concept study22–45Moderate to severe endometriosis scored with ASRM criteriaLetrozole; norethindrone acetate; calcium citrate, vitamin DDosage and intervention: 2.5 mg letrozole; 2.5 mg norethindrone acetate; 1250 mg calcium citrate; 800 IU vitamin D

      Duration: 6 months
      ASRM score, pain scoreSix months after treatment: lower ASRM score and lower pain scoreASRM: P = 0.0013

      Pain: P < 0.001
      Very low
      • Almassinokiani F.
      • Khodaverdi S.
      • Solaymani-Dodaran M.
      • Akbari P.
      • Pazouki A.
      Effects of Vitamin D on Endometriosis-Related Pain: A Double-Blind Clinical Trial.


      n = 39
      Randomized double-blind clinical trial15–40Minimal to severe endometriosisVitamin D3Dosage: 50,000 IU vitamin D3 weekly

      Intervention: vitamin D3

      Duration: 12 weeks
      VAS scoreNo difference in VAS score 4 weeks after end of study between intervention and control groupPelvic pain after intervention: P = 0.24

      Dysmenorrhoea after intervention: P = 0.45
      Low
      Fatty acids
      • Indraccolo U.
      • Barbieri F.
      Effect of palmitoylethanolamide-polydatin combination on chronic pelvic pain associated with endometriosis: preliminary observations.
      )

      n = 4
      Prospective clinical study1 = 25, 2 = 27, 3 = 40, 4 = 451 = uterus, left uterosacral ligament

      2 = ovarian, uterosacral ligaments

      3 = bladder, uterosacral ligaments

      4 = ovarian, rectovaginal septum
      Palmitoylethanolamide and polydatinDosage and intervention: palmitoylethanolamide 400 mg

      Polydatin 40 mg, twice a day

      Duration: 3 months
      VAS (for chronic pelvic pain, dysmenorrhoea, deep dyspareunia, dyschezia and dysuria)

      Use of analgesics
      Pain scores chronic pelvic pain and dyspareunia decreased after 1 and 3 months

      No significant difference in dysmenorrhoea, dyschezia, dysuria

      Reduction in use of analgesics after 1, 2 and 3 months
      Pain score chronic pelvic pain:

      P < 0.0069 after 1 month, no significant further decrease after 2 and 3 months

      Dyspareunia:

      P < 0.0132 after 1 month, no significant further decrease after 2 and 3 months

      Use of analgesics: P < 0.0176 after 1 month, no significant further decrease after 2 and 3 months
      Very low
      • Cobellis L.
      • Castaldi M.A.
      • Giordano V.
      • Trabucco E.
      • De Franciscis P.
      • Torella M.
      • Colacurci N.
      Effectiveness of the association micronized N-Palmitoylethanolamine (PEA)-transpolydatin in the treatment of chronic pelvic pain related to endometriosis after laparoscopic assessment: a pilot study.


      n = 61
      Randomized double-blind parallel-group placebo-controlled clinical study24–61ASRM stage I and IIN-palmitoylethanolamine and transpolydatinDosage and intervention:

      Group A:

      palmitoylethanolamine + transpolydatin 400 mg + 40 mg twice a day

      Group B:

      placebo tablet; unclear how many tablets/day

      Group C:

      celecoxib, 200 mg twice a day, 7 days

      Duration: 3 months
      VAS (for pelvic pain, dyspareunia and dysmenorrhoea)VAS score lower in N-palmitoylethanolamine and transpolydatin compared with placebo.

      VAS score lower in celecoxib compared with N-palmitoylethanolamine and transpolydatin
      P < 0.001

      P < 0.001
      Low
      • Giugliano E.
      • Cagnazzo E.
      • Soave I.
      • Lo Monte G.
      • Wenger J.M.
      • Marci R.
      The adjuvant use of N-palmitoylethanolamine and transpolydatin in the treatment of endometriotic pain.


      n = 47
      Prospective clinical study24–45Ovarian endometriosis and rectovaginal endometriosisN-palmitoylethanolamine and transpolydatinDosage and intervention:

      palmitoylethanolamine 400 mg + transpolydatin 40 mg, twice a day

      Duration: 3 months
      VAS (for chronic pelvic pain, dysmenorrhea, dyspareunia and dyscheziaMeasurement at t = 0 (beginning treatment), after 30, 60 and 90 days

      After 30 days: lower VAS
      P < 0.0001 after 30 days for chronic pelvic pain, dysmenorrhoea, dyspareunia

      P < 0.001 after 30 days for dyschezia
      Very low
      • De Leo V.
      • Cagnacci A.
      • Cappelli V.
      • Biasioli A.
      • Leonardi D.
      • Seracchioli R.
      Role of a natural integrator based on lipoic acid, palmitoiletanolamide and myrrh in the treatment of chronic pelvic pain and endometriosis.


      n = 60
      Prospective multicentre clinical study20–39Ovarian endometriosisAlpha-lipoic acid, palmitoiethanolamide (PEA), myrrhDosage and intervention:

      400 mg alpha-lipoic acid, 300 mg PEA, 100 mg myrrh, two tablets a day

      Duration: 6 months
      VAS for dysmenorrhea, pelvic pain and dyspareunia at start and after 3 and 6 months

      Volume of endometrial ovarian cyst at start, after 3 and 6 months with ultrasound assessment
      Chronic pelvic pain and dysmenorrhoea: after 3 and after 6 months significantly lower than at start

      Dyspareunia after 6 months significantly lower than at start

      Cyst volume: not changed after 3 and 6 months
      Chronic pelvic pain and dysmenorrhoea:

      P < 0.05 after 3 and after 6 months

      Dyspareunia: P < 0.05 after 6 months
      Very low
      Antioxidants
      • Morales-Prieto D.M.
      • Herrmann J.
      • Osterwald H.
      • Kochhar P.S.
      • Schleussner E.
      • Market U.R.
      • Oettel M.
      Comparison of dienogest effects upon 3,3’-diindolylmethane supplementation in models of endometriosis and clinical cases.


      n = 8
      Case series34–51Surgically confirmed endometriosis3,3-diindolylmethane (DIM); dienogest (DNG)Dosage and intervention:

      Group 1: 2 mg DNG once per day and 100 mg DIM three times per day

      Group 2:

      2 mg DNG once per day

      Duration: 3 months
      Endometriosis-associated pelvic pain (EAPP) using VAS after 1, 2 and 3 months

      Bleeding pattern after 1, 2 and 3 months
      Pain: EAPP was lower in DNG group compared with DNG-DIM group at start of study. At the end of study, EAPP was significantly decreased in both groups. EAPP was higher in DNG group than in DNG-DIM group

      Bleeding pattern: fewer bleeding days and less heavy bleeding in DNG-DIM group as compared with DNG group
      Pain: EAPP DNG-DIM vs DNG group P < 0.05

      Bleeding pattern: number of days of bleeding DNG-DIM vs DNG alone P < 0.05
      Very low
      Gluten and soy
      • Chandrareddy A.
      • Muneyyirci-Delale O.
      • McFarlane S.I.
      • Murad O.M.
      Adverse effects of phytoestrogens on reproductive health: a report of three cases.


      n = 2
      Case report35, 431. Ovarian

      2. Not described
      No soySoy-free dietNot defined1. After 3 months without soy: free of dysmenorrhoea, abdominal pain subsided

      2. Improvement of symptoms, became pregnant
      n/aVery low
      • Caserta D.
      • Matteucci E.
      • Ralli E.
      • Bordi G.
      • Moscarini M.
      Celiac disease and endometriosis: an insidious and worrisome association hard to diagnose: a case report.


      n = 1
      Case report34Ovarian endometriosisNo glutenGluten-free dietNot definedPregnancyn/aVery low
      More than one dietary intervention
      • Sesti F.
      • Pietropolli A.
      • Capozzolo T.
      • Broccoli P.
      • Pierangeli S.
      • Bollea M.R.
      • Piccione E.
      Hormonal suppression treatment or dietary therapy versus placebo in the control of painful symptoms after conservative surgery for endometriosis stage III-IV. A randomized comparative trial.


      n = 222
      Randomized comparative trialReproductive age up to 40rAFS III–IVVitamin B6, A, C, E; Ca, Mg, Se, Zn, Fe; VSL3 lactic ferments (Bifidobacterium breve, Bifidobacterium longum, Bifidobacterium infantis, Lactobacillus acidophilus, Lactobacillus casei, Lactobacillus bulgaricus, Streptococcus thermophilus); omega-3 and omega-6 fatty acidsDosage and intervention:

      surgical intervention: conservative surgery.

      Post-surgical treatment:

      -placebo (n = 110)

      -GnRH analogue 3.75 mg/month (n = 39)

      -OC continuously (n = 38)

      -dietary intervention (n = 35)

      A different

      dietary protocol was assigned according to body mass index, physical activity, and job of each woman

      Duration: 6 months
      Pain (VAS score) and QoL (SF36) 18 months after surgery18 months after surgery: pain and QoL equal in hormonal treatment group and dietary group, but less pain and better QoL in both treatment groups compared with placebo groupPain scores: P < 0.001Low
      Author/date, number of patientsStudy design / type of studyAge (years)Type of endometriosisDietary componentDosage / intervention / durationEnd-point of studyResultP-valueQuality of evidence (GRADE)
      • Sesti F.
      • Capozzolo T.
      • Pietropolli A.
      • Marziali M.
      • Bollea M.R.
      • Piccione E.
      Recurrence rate of endometrioma after laparoscopic cystectomy: a comparative randomized trial between post-operative hormonal suppression treatment or dietary therapy vs. placebo.


      n = 240
      Randomized comparative trialReproductive age up to 40EndometriomaVitamin B6, A, C, E; Ca, Mg, Se, Zn, Fe; VSL3 lactic ferments (Bifidobacterium breve, Bifidobacterium longum, Bifidobacterium infantis, Lactobacillus acidophilus, Lactobacillus casei, Lactobacillus bulgaricus, Streptococcus thermophilus); omega-3 and omega-6 fatty acidsDosage and intervention:

      surgical intervention: cystectomy and adhesiolysis

      Post-surgical treatment:

      -placebo (n = 60)

      -GnRH analogue 3.75 mg/month (n = 58)

      -OC continuously (n = 60)

      -dietary intervention (n = 62)

      A different

      dietary protocol was assigned according to body mass index, physical activity, and job of each woman

      Duration: 6 months
      Recurrence of endometrioma 18 months after surgeryNo differences in recurrence between study groupsP = 0.544Low
      • Moore J.S.
      • Gibson P.R.
      • Perry R.E.
      • Burgell R.E.
      Endometriosis in patients with irritable bowel syndrome: Specific symptomatic and demographic profile, and response to the low FODMAP diet.


      n = 59
      Retrospective study28 (16–65)Not described. (Patients had surgically confirmed endometriosis and IBS)Low FODMAPDosage: no FODMAP

      Intervention: low FODMAP diet

      Duration: effect was reported after 4 weeks
      Response to low FODMAP, defined as >50% improvement of symptoms in women with endometriosis and IBS, compared with response to low FODMAP in patients with IBS aloneAdherence to low FODMAP n = 55 (93%), response to low FODMAP n = 43 (72%)Response: P = 0.001Very low
      ASRM = American Society for Reproductive Medicine; FODMAP = fermentable oligosaccharides, disaccharides, monosaccharides and polyols; GnRH = gonadotrophin-releasing hormone; IBS = irritable bowel syndrome; QoL = quality of life; VAS = visual analogue scale.

      Assessment of risk of bias

      The quality of included studies, including assessment of risk of bias, was assessed independently by both reviewers using the GRADE criteria (
      • Guyatt G.
      • Oxman A.D.
      • Akl E.A.
      • Kunz R.
      • Vist G.
      • Brozek J.
      • Norris S.
      • Falck-Ytter Y.
      • Glasziou P.
      • DeBeer H.
      • Jaeschke R.
      • Rind D.
      • Meerpohl J.
      • Dahm P.
      • Schünemann H.J.
      GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables.
      ) (Table 2). In case of disagreement between the reviewers, discussion took place until consensus was reached.
      Table 2Quality of the included studies according to the GRADE criteria
      StudyStart1. Limitation in study design2. Imprecision3. Inconsistency4. Indirectness5. Publication biasFactors increasing the quality of the studyConclusion
      Vitamin D
      Ailawadi, 2004Low (Phase 2 open-label non-randomized proof of concept study)Serious: lack of control groupSerious: small study groupNoSerious: very heterogeneous intervention: combination of hormonal treatment and vitamin D, unclear what causes the effectNoNoVery low quality (downgrade 3 levels due to 1, 2, 4)
      Almassinokiani, 2016High (RCT)NoSerious: small and heterogeneous group of patientsNoNoSerious: negative study results, risk of journal selectionNoLow quality (downgrade two levels due to 2)
      Fatty acids
      Indraccolo, 2010Low (observational studies)Serious: case seriesNot seriousNoNoNoNoVery low quality (downgrade 1 level due to 1)
      Cobellis, 2011High (RCT)Serious: lack of blindingNoSerious: heterogeneity of results: in two out of three groups, patients are very satisfied to very unsatisfied within the same study groupNot seriousNoNoLow quality (downgrade two levels due to 1,3)
      Giugliano, 2013Low (prospective clinical study)Serious: lack of control groupNoNoNot seriousNoNoVery low quality (downgrade one level due to 1)
      • De Leo V.
      • Cagnacci A.
      • Cappelli V.
      • Biasioli A.
      • Leonardi D.
      • Seracchioli R.
      Role of a natural integrator based on lipoic acid, palmitoiletanolamide and myrrh in the treatment of chronic pelvic pain and endometriosis.
      Low (open-label prospective clinical study)Serious: lack of control groupSerious: small study groupNoNoNoNoVery low quality (downgrade 2 levels due to 1, 2)
      Antioxidants
      Morales-Prieto, 2018Low (observational studies)Serious: case series; lack of group of cases using DIM aloneNot seriousNoSerious: use of surrogacy outcome: bleeding pattern; and lack of cases using DIM aloneNoNoVery low quality (downgrade 2 levels due to 1, 4)
      Gluten and soy
      Chandrareddy, 2008Low quality (observational study)Serious: case reportNoNoSerious: small and different characteristics of the casesNoNoVery low quality
      Caserta, 2014Low quality (observational study)Serious: case reportNoSerious: unclear what disease caused effect of interventionSerious: small research group, unclear follow-upNoNoVery low quality
      More than one dietary intervention
      Sesti, 2007High (RCT)NoNoNoVery serious: heterogeneous diet intervention and heterogeneous surgical interventions, unclear what diet intervention or which surgical therapy causes which effectNoNoLow quality (downgrade two levels due to 4)
      Sesti, 2009High (RCT)NoNoNoVery serious: heterogeneous diet intervention, unclear what intervention causes which effect; type of endometriosis varies from ASRM I to IV despite design that says ovarian endometriomaNoNoLow quality (downgrade two levels due to 4)
      Moore, 2016Low quality (observational study)NoNoNoSerious: large difference in study population and number of patients in each groupSerious: possible over-interpretation of positive results of diet in subgroup of original study populationNoVery low quality (downgrade two levels due to combination of 4 and 5)
      ASRM = American Society for Reproductive Medicine; DIM = diindolylmethane; RCT = randomized controlled trial.

      Data synthesis and analysis

      The nature of the evidence retrieved by the literature search was such that meta-analysis was not possible, because a limited number of articles was included, the included studies were small and described very heterogeneous dietary factors. For this reason, a narrative synthesis of data is provided.

      Results

      Study selection

      The search retrieved 454 articles (Search 1 = 111, Search 2 = 343). After reading titles and abstracts, 387 failed to meet the inclusion criteria. The full-text versions of the remaining 67 studies were read in their entirety. Of these 67 studies, 55 were excluded because they did not meet the inclusion criteria. This left 12 included studies (
      • Ailawadi R.K.
      • Jobanputra S.
      • Kataria M.
      • Gurates B.
      • Bulun S.E.
      Treatment of endometriosis and chronic pelvic pain with letrozole and norethindrone acetate: a pilot study.
      ;
      • Almassinokiani F.
      • Khodaverdi S.
      • Solaymani-Dodaran M.
      • Akbari P.
      • Pazouki A.
      Effects of Vitamin D on Endometriosis-Related Pain: A Double-Blind Clinical Trial.
      ;
      • Caserta D.
      • Matteucci E.
      • Ralli E.
      • Bordi G.
      • Moscarini M.
      Celiac disease and endometriosis: an insidious and worrisome association hard to diagnose: a case report.
      ;
      • Chandrareddy A.
      • Muneyyirci-Delale O.
      • McFarlane S.I.
      • Murad O.M.
      Adverse effects of phytoestrogens on reproductive health: a report of three cases.
      ;
      • Cobellis L.
      • Castaldi M.A.
      • Giordano V.
      • Trabucco E.
      • De Franciscis P.
      • Torella M.
      • Colacurci N.
      Effectiveness of the association micronized N-Palmitoylethanolamine (PEA)-transpolydatin in the treatment of chronic pelvic pain related to endometriosis after laparoscopic assessment: a pilot study.
      ;
      • De Leo V.
      • Cagnacci A.
      • Cappelli V.
      • Biasioli A.
      • Leonardi D.
      • Seracchioli R.
      Role of a natural integrator based on lipoic acid, palmitoiletanolamide and myrrh in the treatment of chronic pelvic pain and endometriosis.
      ;
      • Giugliano E.
      • Cagnazzo E.
      • Soave I.
      • Lo Monte G.
      • Wenger J.M.
      • Marci R.
      The adjuvant use of N-palmitoylethanolamine and transpolydatin in the treatment of endometriotic pain.
      ;
      • Indraccolo U.
      • Barbieri F.
      Effect of palmitoylethanolamide-polydatin combination on chronic pelvic pain associated with endometriosis: preliminary observations.
      ;
      • Moore J.S.
      • Gibson P.R.
      • Perry R.E.
      • Burgell R.E.
      Endometriosis in patients with irritable bowel syndrome: Specific symptomatic and demographic profile, and response to the low FODMAP diet.
      ;
      • Morales-Prieto D.M.
      • Herrmann J.
      • Osterwald H.
      • Kochhar P.S.
      • Schleussner E.
      • Market U.R.
      • Oettel M.
      Comparison of dienogest effects upon 3,3’-diindolylmethane supplementation in models of endometriosis and clinical cases.
      ;
      • Sesti F.
      • Pietropolli A.
      • Capozzolo T.
      • Broccoli P.
      • Pierangeli S.
      • Bollea M.R.
      • Piccione E.
      Hormonal suppression treatment or dietary therapy versus placebo in the control of painful symptoms after conservative surgery for endometriosis stage III-IV. A randomized comparative trial.
      ,
      • Sesti F.
      • Capozzolo T.
      • Pietropolli A.
      • Marziali M.
      • Bollea M.R.
      • Piccione E.
      Recurrence rate of endometrioma after laparoscopic cystectomy: a comparative randomized trial between post-operative hormonal suppression treatment or dietary therapy vs. placebo.
      ) (Figure 1). (See Supplementary Table 1 for details about the excluded studies.)
      Figure 1
      Figure 1Flow diagram of the selection of articles included in this review.

      Study characteristics

      This review included four randomized clinical trials (
      • Almassinokiani F.
      • Khodaverdi S.
      • Solaymani-Dodaran M.
      • Akbari P.
      • Pazouki A.
      Effects of Vitamin D on Endometriosis-Related Pain: A Double-Blind Clinical Trial.
      ;
      • Cobellis L.
      • Castaldi M.A.
      • Giordano V.
      • Trabucco E.
      • De Franciscis P.
      • Torella M.
      • Colacurci N.
      Effectiveness of the association micronized N-Palmitoylethanolamine (PEA)-transpolydatin in the treatment of chronic pelvic pain related to endometriosis after laparoscopic assessment: a pilot study.
      ;
      • Sesti F.
      • Pietropolli A.
      • Capozzolo T.
      • Broccoli P.
      • Pierangeli S.
      • Bollea M.R.
      • Piccione E.
      Hormonal suppression treatment or dietary therapy versus placebo in the control of painful symptoms after conservative surgery for endometriosis stage III-IV. A randomized comparative trial.
      , 2000), four non-randomized clinical trials (
      • Ailawadi R.K.
      • Jobanputra S.
      • Kataria M.
      • Gurates B.
      • Bulun S.E.
      Treatment of endometriosis and chronic pelvic pain with letrozole and norethindrone acetate: a pilot study.
      ;
      • Indraccolo U.
      • Barbieri F.
      Effect of palmitoylethanolamide-polydatin combination on chronic pelvic pain associated with endometriosis: preliminary observations.
      ; Giugliano et al.,
      • De Leo V.
      • Cagnacci A.
      • Cappelli V.
      • Biasioli A.
      • Leonardi D.
      • Seracchioli R.
      Role of a natural integrator based on lipoic acid, palmitoiletanolamide and myrrh in the treatment of chronic pelvic pain and endometriosis.
      ), one retrospective study (
      • Moore J.S.
      • Gibson P.R.
      • Perry R.E.
      • Burgell R.E.
      Endometriosis in patients with irritable bowel syndrome: Specific symptomatic and demographic profile, and response to the low FODMAP diet.
      ), one case series (
      • Morales-Prieto D.M.
      • Herrmann J.
      • Osterwald H.
      • Kochhar P.S.
      • Schleussner E.
      • Market U.R.
      • Oettel M.
      Comparison of dienogest effects upon 3,3’-diindolylmethane supplementation in models of endometriosis and clinical cases.
      ) and two case reports (
      • Caserta D.
      • Matteucci E.
      • Ralli E.
      • Bordi G.
      • Moscarini M.
      Celiac disease and endometriosis: an insidious and worrisome association hard to diagnose: a case report.
      ;
      • Chandrareddy A.
      • Muneyyirci-Delale O.
      • McFarlane S.I.
      • Murad O.M.
      Adverse effects of phytoestrogens on reproductive health: a report of three cases.
      ). After grading the evidence, the quality of the evidence in this review turned out to be low to very low. Most studies were small, lacked control groups and involved either a heterogeneous patient group or a heterogeneous intervention (Table 1).

      Risk of bias of included studies

      Imprecision, inconsistency, indirectness and/or publication bias were found in all included studies (Table 2).

      Synthesis of results

      Effective nutrients

      There were no articles meeting the inclusion criteria for all 26 dietary components implemented in the search. In studies meeting the inclusion criteria, effects of vitamin D, fatty acids, antioxidants, gluten, soy, and certain combinations of nutrients were reported. Described below is the effect of the different dietary components per component and per diet.

      Vitamin D

      Two studies with opposite results were found about vitamin D in relation to endometriosis. No difference was found in pain after surgery for endometriosis between women taking oral vitamin D (cholecalciferol or 1,25-dihydroxyvitamin D3) and placebo in a randomized double-blind trial (
      • Almassinokiani F.
      • Khodaverdi S.
      • Solaymani-Dodaran M.
      • Akbari P.
      • Pazouki A.
      Effects of Vitamin D on Endometriosis-Related Pain: A Double-Blind Clinical Trial.
      ). In another study, a different concept was investigated. Women with endometriosis were treated with a combination of letrozole, norethindrone acetate, calcium citrate and vitamin D. Pain scores as well as American Society for Reproductive Medicine (ASRM) scores were lower after treatment compared with before treatment (
      • Ailawadi R.K.
      • Jobanputra S.
      • Kataria M.
      • Gurates B.
      • Bulun S.E.
      Treatment of endometriosis and chronic pelvic pain with letrozole and norethindrone acetate: a pilot study.
      ). The vitamin D given in this study was given as add-back therapy together with calcium in order to prevent bone loss. Therefore it was unclear whether vitamin D played a role in the observed effect.

      Fatty acids

      Four studies were found about fatty acids and their effects on endometriosis (
      • Cobellis L.
      • Castaldi M.A.
      • Giordano V.
      • Trabucco E.
      • De Franciscis P.
      • Torella M.
      • Colacurci N.
      Effectiveness of the association micronized N-Palmitoylethanolamine (PEA)-transpolydatin in the treatment of chronic pelvic pain related to endometriosis after laparoscopic assessment: a pilot study.
      ;
      • De Leo V.
      • Cagnacci A.
      • Cappelli V.
      • Biasioli A.
      • Leonardi D.
      • Seracchioli R.
      Role of a natural integrator based on lipoic acid, palmitoiletanolamide and myrrh in the treatment of chronic pelvic pain and endometriosis.
      ;
      • Giugliano E.
      • Cagnazzo E.
      • Soave I.
      • Lo Monte G.
      • Wenger J.M.
      • Marci R.
      The adjuvant use of N-palmitoylethanolamine and transpolydatin in the treatment of endometriotic pain.
      ;
      • Indraccolo U.
      • Barbieri F.
      Effect of palmitoylethanolamide-polydatin combination on chronic pelvic pain associated with endometriosis: preliminary observations.
      ). In three of these studies, with a total study group of 112 women aged 24–61, an intervention with palmitoylethanolamine and transpolydatin was carried out (
      • Cobellis L.
      • Castaldi M.A.
      • Giordano V.
      • Trabucco E.
      • De Franciscis P.
      • Torella M.
      • Colacurci N.
      Effectiveness of the association micronized N-Palmitoylethanolamine (PEA)-transpolydatin in the treatment of chronic pelvic pain related to endometriosis after laparoscopic assessment: a pilot study.
      ;
      • Giugliano E.
      • Cagnazzo E.
      • Soave I.
      • Lo Monte G.
      • Wenger J.M.
      • Marci R.
      The adjuvant use of N-palmitoylethanolamine and transpolydatin in the treatment of endometriotic pain.
      ;
      • Indraccolo U.
      • Barbieri F.
      Effect of palmitoylethanolamide-polydatin combination on chronic pelvic pain associated with endometriosis: preliminary observations.
      ). In all three studies there was a lower visual analogue scale (VAS) score for endometriosis-related pain in the intervention group as compared with the control group. The fourth study investigated the effect of alpha-lipoic acid, palmitoylethanolamide and myrrh on both the volume of endometriosis cysts and pain in women with these cysts. Cyst volume did not change after the intervention, but chronic pelvic pain and dysmenorrhoea evaluated with VAS score significantly decreased (
      • De Leo V.
      • Cagnacci A.
      • Cappelli V.
      • Biasioli A.
      • Leonardi D.
      • Seracchioli R.
      Role of a natural integrator based on lipoic acid, palmitoiletanolamide and myrrh in the treatment of chronic pelvic pain and endometriosis.
      ).

      Antioxidants

      In a case series of eight women, treatment with the antioxidant diindolylmethane (DIM) together with dienogest suppressed pain and bleeding in women with endometriosis as compared with treatment with dienogest alone (
      • Morales-Prieto D.M.
      • Herrmann J.
      • Osterwald H.
      • Kochhar P.S.
      • Schleussner E.
      • Market U.R.
      • Oettel M.
      Comparison of dienogest effects upon 3,3’-diindolylmethane supplementation in models of endometriosis and clinical cases.
      ).

      Gluten

      One case reports a woman with coeliac disease having an endometriosis cyst and who became pregnant after following a gluten-free diet (
      • Caserta D.
      • Matteucci E.
      • Ralli E.
      • Bordi G.
      • Moscarini M.
      Celiac disease and endometriosis: an insidious and worrisome association hard to diagnose: a case report.
      ). However, it was not clear whether avoiding gluten had a positive effect on the coeliac disease, as was expected, and thereby gave relief of all abdominal complaints, or whether avoiding gluten could also be effective against endometriosis.

      Soy

      In a small case series, two women with endometriosis became pain-free after a soy-free diet (
      • Chandrareddy A.
      • Muneyyirci-Delale O.
      • McFarlane S.I.
      • Murad O.M.
      Adverse effects of phytoestrogens on reproductive health: a report of three cases.
      ). This positive effect of avoiding soy, which is rich in phytoestrogens, on endometriosis-associated pain seems logical because endometriosis is an oestrogen-dependent disease. However, the amount of phytoestrogens present in soy is relatively low, making the effect of avoiding soy on suppressing endometriosis-related symptoms questionable.

      Combination of nutrients

      Sesti and coworkers investigated the effects of a diet consisting of a combination of vitamins B6, A, C and E, minerals calcium (Ca), magnesium (Mg), selenium (Se), zinc (Zn) and iron (Fe), lactobacilli and omega-3 and -6 fatty acids (
      • Sesti F.
      • Pietropolli A.
      • Capozzolo T.
      • Broccoli P.
      • Pierangeli S.
      • Bollea M.R.
      • Piccione E.
      Hormonal suppression treatment or dietary therapy versus placebo in the control of painful symptoms after conservative surgery for endometriosis stage III-IV. A randomized comparative trial.
      ,
      • Sesti F.
      • Capozzolo T.
      • Pietropolli A.
      • Marziali M.
      • Bollea M.R.
      • Piccione E.
      Recurrence rate of endometrioma after laparoscopic cystectomy: a comparative randomized trial between post-operative hormonal suppression treatment or dietary therapy vs. placebo.
      ). Dosages of nutrients were adjusted to a patient's individual parameters including body mass index and physical activity. Following this diet, pain was less and quality of life after surgery for endometriosis was higher compared with women in a placebo group. The effects of diet were equal to the effects of post-surgical hormonal therapy (
      • Sesti F.
      • Pietropolli A.
      • Capozzolo T.
      • Broccoli P.
      • Pierangeli S.
      • Bollea M.R.
      • Piccione E.
      Hormonal suppression treatment or dietary therapy versus placebo in the control of painful symptoms after conservative surgery for endometriosis stage III-IV. A randomized comparative trial.
      ). Using the same dietary intervention in a group of patients undergoing cystectomy and adhesiolysis because of endometrioma, the authors found no differences in recurrence of endometrioma in women following the diet, women using GnRH analogues and in the placebo group (
      • Sesti F.
      • Capozzolo T.
      • Pietropolli A.
      • Marziali M.
      • Bollea M.R.
      • Piccione E.
      Recurrence rate of endometrioma after laparoscopic cystectomy: a comparative randomized trial between post-operative hormonal suppression treatment or dietary therapy vs. placebo.
      ). The authors speculated that the recurrence risk may reflect successful reseeding, reimplantation and regrowth of the ectopic endometrium.
      In another study, the low fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) diet, which was used as a therapy for patients with irritable bowel syndrome, turned out to be effective in women with irritable bowel syndrome (IBS) and endometriosis (
      • Moore J.S.
      • Gibson P.R.
      • Perry R.E.
      • Burgell R.E.
      Endometriosis in patients with irritable bowel syndrome: Specific symptomatic and demographic profile, and response to the low FODMAP diet.
      ). Women with endometriosis and IBS had a higher response to the low FODMAP diet than patients with IBS alone. FODMAP are short-chain carbohydrates that are poorly absorbed in the small bowel and highly fermentable by gut bacteria. Luminal distension is caused by their osmotic effects and gas production. This causes pain and bloating in patients with visceral hypersensitivity, which is not only found in IBS but also in women with endometriosis. Avoiding FODMAP turned out to decrease pain in women with IBS as well as endometriosis, but it was unclear whether this decrease in pain was specific for endometriosis-associated symptoms.

      Discussion

      This systematic review provides evidence for the role of nutrients in the management of endometriosis and reports on the positive effects of adding or avoiding certain nutrients on endometriosis-associated symptoms. In nine studies, nutrients were added to patients’ diets, and in seven of these a positive effect was found. In three studies, nutrients were avoided, with positive effects on endometriosis-associated symptoms as well.
      Inflammation is thought to be one of the main factors in endometriosis. The immune system plays a pivotal role in the pathophysiology of endometriosis as well as in pain and in subfertility associated with it. Different immune cells are involved in the inflammatory response, including cytokines, neutrophils, granulocytes (including mast cells and macrophages), chemokines and different subsets of T-cells (
      • Jiang L.
      • Yan Y.
      • Liu Z.
      • Wang Y.
      Inflammation and endometriosis.
      ). Antioxidants balance oxidative stress, which is present in chronic inflammatory processes. All nutrients that turned out to be effective in suppressing endometriosis-associated pain had anti-inflammatory or antioxidative actions, thereby directly or indirectly suppressing the inflammatory response. Palmitoylethanolamine (PEA) plays a role in controlling inflammation by mast cell activation and has immunosuppressive, analgesic, neuroprotective and antioxidant effects (
      • Lambert D.M.
      • Vandevoorde S.
      • Jonsson K.O.
      • Fowler C.J.
      The palmitoylethanolamide family: a new class of anti-inflammatory agents?.
      ). It is found in small quantities in eggs and peanuts. The presence of activated and degranulating mast cells in deep endometriosis, and the close histological relationship between mast cells and nerves, suggests that mast cells may contribute to the development of pain in endometriosis, possibly by an effect on nerve structures (
      • Cobellis L.
      • Castaldi M.A.
      • Giordano V.
      • Trabucco E.
      • De Franciscis P.
      • Torella M.
      • Colacurci N.
      Effectiveness of the association micronized N-Palmitoylethanolamine (PEA)-transpolydatin in the treatment of chronic pelvic pain related to endometriosis after laparoscopic assessment: a pilot study.
      ;
      • Indraccolo U.
      • Barbieri F.
      Effect of palmitoylethanolamide-polydatin combination on chronic pelvic pain associated with endometriosis: preliminary observations.
      ). Polydatin, a natural glucoside of resveratrol, has anti-inflammatory, antioxidant and anti-chemotactic activities and is present in berries, grapes and peanuts (
      • Cobellis L.
      • Castaldi M.A.
      • Giordano V.
      • Trabucco E.
      • De Franciscis P.
      • Torella M.
      • Colacurci N.
      Effectiveness of the association micronized N-Palmitoylethanolamine (PEA)-transpolydatin in the treatment of chronic pelvic pain related to endometriosis after laparoscopic assessment: a pilot study.
      ;
      • Giugliano E.
      • Cagnazzo E.
      • Soave I.
      • Lo Monte G.
      • Wenger J.M.
      • Marci R.
      The adjuvant use of N-palmitoylethanolamine and transpolydatin in the treatment of endometriotic pain.
      ;
      • Indraccolo U.
      • Barbieri F.
      Effect of palmitoylethanolamide-polydatin combination on chronic pelvic pain associated with endometriosis: preliminary observations.
      ). DIM is an antioxidant that is formed in acidic environments from indole-3-carbinol (I3C) which is present in cabbage, Brussels sprouts, broccoli and cardamom (
      • Leong H.
      • Firestone G.L.
      • Bjeldanes L.F.
      Cytostatic effects of 3,3′-diindolylmethane in human endometrial cancer cells result from an estrogen receptor-mediated increase in transforming growth factor-alpha expression.
      ). It has anti-carcinogenic properties, but in oestrogen-sensitive cells it specifically reverses oestrogen effects by inhibiting oestrogen receptor alpha signalling (
      • Auborn K.J.
      • Fan S.
      • Rosen E.M.
      • Goodwin L.
      • Chandraskaren A.
      • Williams D.E.
      • Chen D.
      • Carter T.H.
      Indole-3-carbinol is a negative regulator of estrogen.
      ). The combination of antioxidant and anti-oestrogen activities makes it especially promising for the treatment of endometriosis. The activity of prostaglandins is involved in generating pain. Omega-3 fatty acids selectively modulate specific prostaglandins, whereas vitamin B6 plays a role in the production of oestradiol prostaglandin (
      • Proctor M.L.
      • Murphy P.A.
      Herbal and dietary therapies for primary and secondary dysmenorrhea (review).
      ). By influencing the level of antioxidants and prostaglandins using different dietary components, an environment can be created in which inflammation is suppressed. The combination of different agents with anti-inflammatory actions may result in a synergy of actions, powerful enough to effectively treat endometriosis-related symptoms. It is important to stress that the case series of eight women in which a positive effect of adding antioxidants to the diet was described is too small to draw conclusions about the effectiveness of adding antioxidants to the diet of women with endometriosis.
      Nutrients that were avoided with a positive effect on endometriosis-associated symptoms were soy, gluten and FODMAP. Soy is rich in phytoestrogens and may stimulate oestrogen activity, thereby stimulating endometriosis. By avoiding soy, the amount of phytoestrogens in the diet is reduced, with a possible suppression of endometriosis-associated pain. However, this result was described in only one case series including two women and so there is insufficient evidence to advise women with endometriosis to avoid soy. Gluten is the main structural protein component of wheat, consisting of gliadin and glutenin. The intake of wheat may contribute to the manifestation of a chronic inflammatory response as gliadin and wheatgerm agglutinin can both increase intestinal permeability and thereby activate the immune system (
      • Keita A.V.
      • Soderholm J.D.
      The intestinal barrier and its regulation by neuroimmune factors.
      ). However, only one case report described a positive effect of avoiding gluten on fertility, concerning a woman who not only suffered from endometriosis, but from gluten intolerance as well. It remains unclear whether avoiding gluten is effective for women with endometriosis-associated symptoms, even more so because wholegrains are part of a healthy diet (
      • De Punder K.
      • Pruimboom L.
      The dietary intake of wheat and other cereal grains and their role in inflammation.
      ). One study reported that avoiding FODMAP was effective for women with endometriosis (
      • Moore J.S.
      • Gibson P.R.
      • Perry R.E.
      • Burgell R.E.
      Endometriosis in patients with irritable bowel syndrome: Specific symptomatic and demographic profile, and response to the low FODMAP diet.
      ). However, the patients in this study had both IBS and endometriosis, making it difficult to explain the effects of low FODMAP as specific to suppressing endometriosis alone. Therefore, evidence is insufficient to advise endometriosis patients to adhere to a low FODMAP diet. On the other hand, many women with endometriosis report gastrointestinal symptoms, and many women are diagnosed with endometriosis in combination with IBS (
      • Seaman H.E.
      • Ballard K.D.
      • Wright J.T.
      • de Vries C.S.
      Endometriosis and its coexistence with irritable bowel syndrome and pelvic inflammatory disease: findings from a national case–control study–Part 2.
      ). Hence these dietary changes may reduce pelvic pain symptoms that could be exacerbated by IBS or gastrointestinal symptoms.
      Adding only vitamin D to a patient's diet did not lead to suppression of endometriosis-associated symptoms (
      • Almassinokiani F.
      • Khodaverdi S.
      • Solaymani-Dodaran M.
      • Akbari P.
      • Pazouki A.
      Effects of Vitamin D on Endometriosis-Related Pain: A Double-Blind Clinical Trial.
      ), whereas treatment with letrozole together with vitamin D resulted in lower ASRM scores as well as lower pain scores (
      • Ailawadi R.K.
      • Jobanputra S.
      • Kataria M.
      • Gurates B.
      • Bulun S.E.
      Treatment of endometriosis and chronic pelvic pain with letrozole and norethindrone acetate: a pilot study.
      ). However, theoretically, dietary vitamin D intake and plasma 25-hydroxyvitamin D [25(OH)D] concentration may influence endometriosis and endometriosis-related symptoms because beyond its role in calcium and bone homeostasis, vitamin D influences the immune function and promotes anti-inflammatory processes (
      • Sayegh L.
      • Fuleihan Gel H.
      • Nassar A.H.
      Vitamin D in endometriosis: a causative or confounding factor?.
      ). Vitamin D deficiency has been reported to play a role in the pathogenesis of endometriosis (
      • Muscogiuri G.
      • Altieri B.
      • de Angelis C.
      • Palomba S.
      • Pivonello R.
      • Colao A.
      • Orio F.
      Shedding new light on female fertility: The role of vitamin D.
      ). In a prospective study,
      • Harris H.R.
      • Chavarro J.E.
      • Malspeis S.
      • Willett W.C.
      • Missmer S.A.
      Dairy-food, calcium, magnesium, and vitamin D intake and endometriosis: a prospective cohort study.
      reported that increased plasma 25(OH)D and higher dairy intake was associated with a decreased risk of developing endometriosis.
      This review has a number of strengths. First, the search strategy was broad and thorough, and constructed with an expert librarian. Second, the review has a specific scope. The focus was on the role of diet on symptoms of already established endometriosis, and the research question was formulated accordingly. This was done to find evidence concerning the role of nutrients in active endometriosis, and in order to be able to provide specific dietary advice for women suffering from endometriosis symptoms. For this reason, the search ruled out laboratory and animal studies. Moreover, studies focusing on nutrients that may play a role in the development or in the prevention of endometriosis were not taken into account either.
      The narrow scope of the review may also be a limitation. The specific research question may have led to a limited selection of nutrients for which evidence was found for the effect of suppressing endometriosis symptoms. Moreover, only studies in the English language were included, so there may be relevant articles in other languages that have not been taken into account in this review. Finally, the quality of the evidence found was low to very low. Interpretation of the results of the review can only be done with caution and advice for dietary practice may be of limited value. This holds true especially for the effect of adding antioxidants to the diet and of avoiding gluten and soy, because the effects of these interventions were only described in a case series and in two case reports, respectively. Despite the very low numbers of patients in these studies and hence the impossibility of drawing conclusions for the usefulness of the findings in daily practice, it was decided to include these articles in the review, because many women with endometriosis ask questions about the effects on their symptoms of these specific nutrients. By including these articles in the review, the aim was to raise awareness in medical professionals about considering the role of antioxidants, gluten and soy.
      In conclusion, nutrients with direct or indirect anti-inflammatory properties may be effective in suppressing endometriosis-associated pain. Hence, it may be speculated that foods that are rich in polyunsaturated fatty acids, certain vitamins and minerals, antioxidants, polydatin (resveratrol) and lactobacilli may be implemented in a diet in order to suppress endometriosis symptoms (Table 3). However, it is too early to develop an endometriosis diet based on the results of this review. More studies are needed in order to collect evidence supporting the speculations.
      Table 3Nutrients with a possible positive effect on endometriosis-related symptoms, their sources and their recommended daily amount (

      Dutch Health Council (Gezondheidsraad)., 2015. Richtlijnen goede voeding.https://www.gezondheidsraad.nl/documenten/adviezen/2015/11/04/richtlijnen-goede-voeding-2015. Consulted at 25–8-2019.

      ,

      Dutch Health Council (Gezondheidsraad)., 2018. Voedingsnormen voor vitamines en mineralen voor volwassenen.https://www.gezondheidsraad.nl/documenten/adviezen/2018/09/18/gezondheidsraad-herziet-voedingsnormen-voor-volwassenen. Consulted at 25–8-2019.

      ;
      • Şöhretoğlu D.
      • Yüzbaşıoğlu
      • Baran M.
      • Arroo R.
      • Kuruüzüm-Uz A.
      Recent advances in chemistry, therapeutic properties and sources of polydatin.
      ;

      Whitney, E.N., Rolfes, S.R., 2011. Understanding nutrition, first ed. Belmont, California.

      )
      NutrientNutrient-rich foodsRecommended amount for women
      Fatty acids
      Palmitoylethanolamide (PEA)Eggs, peanutsNo recommended daily amount
      Omega-3 fatty acidsLinolenic acid: oils (flax seed, canola, walnut, wheatgerm, soybean), nuts and seeds (butternuts, flax seeds, walnuts, soybean kernels)

      Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA): human milk, fatty fish
      1% of adequate energy intake
      Omega-6 fatty acidsLinoleic acid: vegetable oils (corn, sunflower, safflower, soybean, cottonseed), poultry fat, nuts (pine nuts, walnuts), seeds (sesame, sunflower and pumpkin)

      Arachidonic acid: meats, poultry, eggs, mayonnaise, margarine
      2% of adequate energy intake
      Vitamins, minerals and antioxidants
      Vitamin ACheese, cream, butter, fortified margarine, butter, eggs, liver, dark leafy greens, deep orange fruits (apricots, cantaloupe), vegetables (sweet potatoes, pumpkin, squash, carrots)680 µg mg/day
      Vitamin B6Meat (chicken breast), fish, poultry, potatoes and other starchy vegetables, legumes, non-citrus fruits (banana, watermelon)1.5 micrograms/day
      Vitamin C(Citrus) fruits, cabbage-type vegetables (Brussels sprouts, cauliflower), dark green vegetables (bell pepper, broccoli), cantaloupe, strawberries, lettuce, tomatoes, potatoes, papayas, mangoes, kiwi75 µg/day
      Vitamin DFortified foods such as milk, margarine, butter. Egg yolks, liver, fatty fish, veal10 µg/day (AI)
      Vitamin EPolyunsaturated plant oils, leafy green vegetables, wheatgerm, wholegrains, liver, egg yolks, nuts, seeds, avocado11 mg/day
      CalciumMilk, cheese, yoghurt, small fish with bones (sardines), tofu, greens (Chinese cabbage, broccoli, kale)Age 25–49 years: 950 mg/day
      IronRed meat, eggs, fish, shellfish, poultry, dried fruits, tomatoesPre-menopausal 16 mg/day

      Post-menopausal 11 mg/day
      MagnesiumNuts (cashews), seeds, avocado, dried fruits, cacao powder, wholegrains350 mg/day
      SeleniumSeafood, meat, wholegrains, fruits, vegetables70 µg/day
      ZincRed meat, shellfish, wholegrains7 mg/day
      Indole-3-carbinol (I3C)Cruciferous vegetables such as cabbage, Brussels sprouts, broccoliNo recommended daily amount
      PolydatinGrapes, wine, hop cones and pellets, beer, cocoa containing product and chocolateNo recommended daily amount
      LactobacilliYoghurt, kefirNo recommended daily amount
      According to the World Health Organization (WHO), a healthy diet comprises a combination of different foods including staples (like cereals, or starchy tubers or roots like potato, yam, taro or cassava), legumes, fruit and vegetables, and foods from animal sources (meat, fish, eggs and milk) (www.who.int/behealthy). Women with endometriosis may decide to combine fatty acids (from fish, seeds, nuts and cereals) with antioxidants (from vegetables and fruit). It is important to stress to these women that they should pay attention to the WHO advice to maintain a healthy diet in order to avoid nutrient deficiencies. A poor diet, including a shift towards a higher n-6:n-3 fatty acid ratio and a high intake of simple sugars, has been implicated as being one of the factors for developing an inflammatory phenotype (
      • Shelton R.C.
      • Miller A.H.
      Eating ourselves to death (and despair): The contribution of adiposity and inflammation to depression.
      ), which may increase symptoms of endometriosis.
      In response to the wishes of patients to be able to control their endometriosis themselves, the role of diet receives a lot of attention and a lot of dietary advice is given by dieticians and doctors and on the internet. Evidence supporting this advice is scarce. Based on this systematic review, nutrients with direct or indirect anti-inflammatory properties might be effective against endometriosis-related pain symptoms but not on recurrence of endometriomas. Combining different agents may provide a synergistic effect.
      The quality of the evidence was low in the articles included in this review. High-quality intervention studies in women with endometriosis are necessary in order to improve the quality of the evidence. A research agenda has been developed with topics that need to be investigated in order to gain more knowledge about the role of nutrients in endometriosis-related symptoms (Table 4).
      Table 4Research agenda
      Type of studyStudy questionGoal
      Descriptive exploratory studyDo women with endometriosis have a healthy diet according to WHO criteria?

      What dietary intervention is used by women with endometriosis and what is its perceived effectiveness regarding endometriosis related symptoms?
      Finding out whether a healthy diet according to WHO criteria, or changing diet itself is effective against endometriosis related symptoms
      Prospective randomized controlled trialWhat is the effect on endometriosis-related symptoms of adding or omitting specific (combinations of) nutrients to the diet of women with endometriosis, compared with a normal diet?Finding out whether adding or omitting single nutrients or a combination of nutrients is effective against endometriosis-related symptoms
      Laboratory studyWhat amount of effective nutrients is present in specific food products?Finding out which specific food products should be advised in an endometriosis diet and in which amounts per day
      Moreover, the majority of nutrients that were studied were administered in tablets or capsules instead of in food products. It is unclear what specific food products may be effective against endometriosis symptoms and in which amounts they should be implemented in daily eating habits. However, patient empowerment is strongest when patients are able to influence their symptoms by changing their lifestyle on their own account. In order to stimulate patient empowerment by changing dietary habits, it is important to gain more evidence about the effectiveness of specific food products and their appropriate dosages. In future studies, the effects of specific food products and specific dosages, identified based on possibly effective nutrients, should be investigated for use in women with endometriosis.

      References

        • Ailawadi R.K.
        • Jobanputra S.
        • Kataria M.
        • Gurates B.
        • Bulun S.E.
        Treatment of endometriosis and chronic pelvic pain with letrozole and norethindrone acetate: a pilot study.
        Fertil. Steril. 2004; 81: 290-296
        • Almassinokiani F.
        • Khodaverdi S.
        • Solaymani-Dodaran M.
        • Akbari P.
        • Pazouki A.
        Effects of Vitamin D on Endometriosis-Related Pain: A Double-Blind Clinical Trial.
        Med. Sci. Monit. 2016; 22: 4960-4966
        • Armour M.
        • Sinclair J.
        • Chalmers J.K.
        • Smith C.A.
        Self-management strategies amongst Australian women with endometriosis: a national online survey.
        B.M.C. Complement Altern. Med. 2019; 19: 17
        • Arruda M.S.
        • Petta C.A.
        • Abrão M.S.
        • Benetti-Pinto C.L.
        Time elapsed from onset of symptoms to diagnosis of endometriosis in a cohort study of Brazilian women.
        Hum. Reprod. 2003; 18: 756-759
        • Auborn K.J.
        • Fan S.
        • Rosen E.M.
        • Goodwin L.
        • Chandraskaren A.
        • Williams D.E.
        • Chen D.
        • Carter T.H.
        Indole-3-carbinol is a negative regulator of estrogen.
        J. Nutr. 2003; 133: 2470S-2475S
        • Ballard K.
        • Lowton K.
        • Wright J.
        What's the delay? A qualitative study of women's experiences of reaching a diagnosis of endometriosis.
        Fertil. Steril. 2006; 86: 1296-1301
        • Caserta D.
        • Matteucci E.
        • Ralli E.
        • Bordi G.
        • Moscarini M.
        Celiac disease and endometriosis: an insidious and worrisome association hard to diagnose: a case report.
        Clin. Exp. Obstet. Gynecol. 2014; 41: 346-348
        • Chandrareddy A.
        • Muneyyirci-Delale O.
        • McFarlane S.I.
        • Murad O.M.
        Adverse effects of phytoestrogens on reproductive health: a report of three cases.
        Complement Ther. Clin. Pract. 2008; 14: 132-135
        • Cobellis L.
        • Castaldi M.A.
        • Giordano V.
        • Trabucco E.
        • De Franciscis P.
        • Torella M.
        • Colacurci N.
        Effectiveness of the association micronized N-Palmitoylethanolamine (PEA)-transpolydatin in the treatment of chronic pelvic pain related to endometriosis after laparoscopic assessment: a pilot study.
        Eur. J. Obstet. Gynecol. Reprod. Biol. 2011; 158: 82-86
        • De Graaff A.A.
        • D'Hooghe T.M.
        • Dunselman G.A.J.
        • Dirksen C.D.
        • Hummelshoj L.
        • Simoens S.
        • WERF EndoCost Consortium
        The significant effect of endometriosis on physical, mental and social wellbeing: results from an international cross–sectional survey.
        Hum. Reprod. 2013; 28: 2677-2685
        • De Leo V.
        • Cagnacci A.
        • Cappelli V.
        • Biasioli A.
        • Leonardi D.
        • Seracchioli R.
        Role of a natural integrator based on lipoic acid, palmitoiletanolamide and myrrh in the treatment of chronic pelvic pain and endometriosis.
        Minerva Ginecol. 2019; 71: 191-195
        • De Punder K.
        • Pruimboom L.
        The dietary intake of wheat and other cereal grains and their role in inflammation.
        Nutrients. 2013; 5: 771-787
        • Dunselman G.A.
        • Vermeulen N.
        • Becker C.
        • Calhaz-Jorge C.
        • D'Hooghe T.
        • De Bie B.
        • Heikinheimo O.
        • Horne A.W.
        • Kiesel L.
        • Nap A.
        • Prentice A.
        • Saridogan E.
        • Soriano D.
        • Nelen W.
        ESHRE guideline: management of women with endometriosis.
        Hum. Reprod. 2014; 29: 400-412
      1. Dutch Health Council (Gezondheidsraad)., 2015. Richtlijnen goede voeding.https://www.gezondheidsraad.nl/documenten/adviezen/2015/11/04/richtlijnen-goede-voeding-2015. Consulted at 25–8-2019.

      2. Dutch Health Council (Gezondheidsraad)., 2018. Voedingsnormen voor vitamines en mineralen voor volwassenen.https://www.gezondheidsraad.nl/documenten/adviezen/2018/09/18/gezondheidsraad-herziet-voedingsnormen-voor-volwassenen. Consulted at 25–8-2019.

        • Giudice L.C.
        Clinical practice. Endometriosis.
        N. Engl. J. Med. 2010; 362: 2389-2398
        • Giugliano E.
        • Cagnazzo E.
        • Soave I.
        • Lo Monte G.
        • Wenger J.M.
        • Marci R.
        The adjuvant use of N-palmitoylethanolamine and transpolydatin in the treatment of endometriotic pain.
        Eur. J. Obstet. Gynecol. Reprod. Biol. 2013; 168: 209-213
        • Guyatt G.
        • Oxman A.D.
        • Akl E.A.
        • Kunz R.
        • Vist G.
        • Brozek J.
        • Norris S.
        • Falck-Ytter Y.
        • Glasziou P.
        • DeBeer H.
        • Jaeschke R.
        • Rind D.
        • Meerpohl J.
        • Dahm P.
        • Schünemann H.J.
        GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables.
        J. Clin. Epidemiol. 2011; 64: 383-394
        • Hadfield R.
        • Mardon H.
        • Barlow D.
        • Kennedy S.
        Delay in the diagnosis of endometriosis: a survey of women from the USA and the UK.
        Hum. Reprod. 1996; 11: 878-880
        • Halme J.
        • Becker S.
        • Hammond M.G.
        • Raj S.G.
        • Talbert L.M.
        Retrograde menstruation in healthy women and in patients with endometriosis.
        Obstet. Gynecol. 1984; 64: 151-154
        • Harris H.R.
        • Chavarro J.E.
        • Malspeis S.
        • Willett W.C.
        • Missmer S.A.
        Dairy-food, calcium, magnesium, and vitamin D intake and endometriosis: a prospective cohort study.
        Am. J. Epidemiol. 2013; 177: 420-430
        • Hudelist G.
        • Fritzer N.
        • Thomas A.
        • Niehues C.
        • Oppelt P.
        • Haas D.
        • Tammaa A.
        • Salzer H.
        Diagnostic delay for endometriosis in Austria and Germany: causes and possible consequences.
        Hum. Reprod. 2012; 7: 3412-3416
        • Indraccolo U.
        • Barbieri F.
        Effect of palmitoylethanolamide-polydatin combination on chronic pelvic pain associated with endometriosis: preliminary observations.
        Eur. J. Obstet. Gynecol. Reprod. Biol. 2010; 150: 76-79
        • Jiang L.
        • Yan Y.
        • Liu Z.
        • Wang Y.
        Inflammation and endometriosis.
        Front. Biosci. 2016; 21: 941-948
        • Keita A.V.
        • Soderholm J.D.
        The intestinal barrier and its regulation by neuroimmune factors.
        Neurogastroenterol. Motil. 2010; 22: 718-733
        • Koga K.
        • Takamura M.
        • Fujii T.
        • Osuga Y.
        Prevention of the recurrence of symptom and lesions after conservative surgery for endometriosis.
        Fertil. Steril. 2015; 104: 793-801
        • Lambert D.M.
        • Vandevoorde S.
        • Jonsson K.O.
        • Fowler C.J.
        The palmitoylethanolamide family: a new class of anti-inflammatory agents?.
        Curr. Med. Chem. 2002; 9: 663-674
        • Leong H.
        • Firestone G.L.
        • Bjeldanes L.F.
        Cytostatic effects of 3,3′-diindolylmethane in human endometrial cancer cells result from an estrogen receptor-mediated increase in transforming growth factor-alpha expression.
        Carcinogenesis. 2001; 22: 1809-1817
        • Moore J.S.
        • Gibson P.R.
        • Perry R.E.
        • Burgell R.E.
        Endometriosis in patients with irritable bowel syndrome: Specific symptomatic and demographic profile, and response to the low FODMAP diet.
        Aust. N. Z. J. Obstet. Gynaecol. 2017; 57: 201-205
        • Morales-Prieto D.M.
        • Herrmann J.
        • Osterwald H.
        • Kochhar P.S.
        • Schleussner E.
        • Market U.R.
        • Oettel M.
        Comparison of dienogest effects upon 3,3’-diindolylmethane supplementation in models of endometriosis and clinical cases.
        Reprod. Biol. 2018; 18: 252-258
        • Muscogiuri G.
        • Altieri B.
        • de Angelis C.
        • Palomba S.
        • Pivonello R.
        • Colao A.
        • Orio F.
        Shedding new light on female fertility: The role of vitamin D.
        Rev. Endocr. Metab. Disord. 2017; 18: 273-283
        • O'Hara R.
        • Rowe H.
        • Fisher J.
        Self-management in condition-specific health: a systematic review of the evidence among women diagnosed with endometriosis.
        B.M.C. Womens Health. 2019; 19: 80
        • Proctor M.L.
        • Murphy P.A.
        Herbal and dietary therapies for primary and secondary dysmenorrhea (review).
        Cochrane database Syst. Rev. 2001; 2CD002124
        • Sampson J.A.
        Peritoneal endometriosis due to menstrual dissemination of endometrial tissue into the peritoneal cavity.
        Am. J. Obstet. Gynecol. 1927; 14: 422-469
        • Sayegh L.
        • Fuleihan Gel H.
        • Nassar A.H.
        Vitamin D in endometriosis: a causative or confounding factor?.
        Metabolism. 2014; 63: 32-41
        • Seaman H.E.
        • Ballard K.D.
        • Wright J.T.
        • de Vries C.S.
        Endometriosis and its coexistence with irritable bowel syndrome and pelvic inflammatory disease: findings from a national case–control study–Part 2.
        BJOG. 2008; 115: 1392-1396
        • Sesti F.
        • Pietropolli A.
        • Capozzolo T.
        • Broccoli P.
        • Pierangeli S.
        • Bollea M.R.
        • Piccione E.
        Hormonal suppression treatment or dietary therapy versus placebo in the control of painful symptoms after conservative surgery for endometriosis stage III-IV. A randomized comparative trial.
        Fertil. Steril. 2007; 88: 1541-1547
        • Sesti F.
        • Capozzolo T.
        • Pietropolli A.
        • Marziali M.
        • Bollea M.R.
        • Piccione E.
        Recurrence rate of endometrioma after laparoscopic cystectomy: a comparative randomized trial between post-operative hormonal suppression treatment or dietary therapy vs. placebo.
        Eur. J. Obstet. Gynecol. Reprod. Biol. 2009; 147: 72-77
        • Shelton R.C.
        • Miller A.H.
        Eating ourselves to death (and despair): The contribution of adiposity and inflammation to depression.
        Prog. Neurobiol. 2010; 91: 275-299
        • Simoens S.
        • Dunselman G.
        • Dirksen C.
        • Hummelshoj L.
        • Bokor A.
        • Brandes I.
        • Brodszky V.
        • Canis M.
        • Colombo G.L.
        • DeLeire T.
        • Falcone T.
        • Graham B.
        • Halis G.
        • Horne A.
        • Kanj O.
        • Kjer J.J.
        • Kristensen J.
        • Lebovic D.
        • Mueller M.
        • Vigano P.
        • Wullschleger M.
        • D'Hooghe T.
        The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres.
        Hum. Reprod. 2012; 27: 1292-1299
        • Şöhretoğlu D.
        • Yüzbaşıoğlu
        • Baran M.
        • Arroo R.
        • Kuruüzüm-Uz A.
        Recent advances in chemistry, therapeutic properties and sources of polydatin.
        Phytochemistry Reviews. 2018; 1: 33
        • Van der Zanden M.
        • Arens M.W.J.
        • Braat D.D.M.
        • Nelen W.L.M.
        • Nap A.W.
        Gynaecologists’ view on diagnostic delay and care performance in endometriosis in the Netherlands.
        Reprod. Biomed. Online. 2018; 37: 761-768
        • Vercellini P.
        • Crosignani P.G.
        • Abbiati A.
        • Somigliana E.
        • Viganò P.
        • Fedele L.
        The effect of surgery for symptomatic endometriosis: the other side of the story.
        Hum. Reprod. Update. 2009; 15: 177-188
      3. Whitney, E.N., Rolfes, S.R., 2011. Understanding nutrition, first ed. Belmont, California.

        • Wu M.H.
        • Shoji Y.
        • Chuang P.C.
        • Tsai S.J.
        Endometriosis: disease pathophysiology and the role of prostaglandins.
        Expert. Rev. Mol. Med. 2007; 16: 1-20

      Biography

      Dr Annemiek Nap, MD, PhD, is initiator of the multidisciplinary team for diagnosis and treatment of endometriosis at Rijnstate Hospital, the Netherlands. She is one of the group leaders of the ESHRE Guideline Development Group ‘Management of women with endometriosis’, and a board member of the World Endometriosis Association.
      Key message
      Evidence for the effect of dietary interventions on endometriosis-related symptoms was of low quality. Dietary interventions may be potentially useful as a self-management strategy for women with endometriosis. However, the evidence is scarce and more research is necessary to identify useful dietary advice for women with endometriosis.